Skip to content
akaturk Academic measurement

Article detail · 2022

Predictive and diagnostic value of serum sVEGFR-1 level in women with preeclampsia: A prospective controlled study

Journal

Turkish Journal of Obstetric and Gynecology

ISSN 1307-699X

The ISSN points to another catalog journal; the name is from the YÖKSİS record.

YÖKSİS OpenAlex Open access · diamond SJR Q3 TR Index Citations 3 Percentile 67.4% FWCI 0.53
Year
2022
Type
article

Data source split

  • YÖKSİS YÖKSİS article record
  • YÖKSİS venue Turkish Journal of Obstetric and Gynecology
  • Catalog match (ISSN) Turk Jinekoloji ve Obstetrik Dernegi Dergisi
  • OpenAlex OpenAlex enrichment (abstract, citations, topics)

Abstract

English (OpenAlex)

Objective: Pre-eclampsia (PE), a pregnancy-specific syndrome consisting of hypertension and proteinuria occurring de novo after the 20th week of gestation, remains the leading cause of maternal and fetal morbidity and mortality worldwide. Endothelial dysfunction is proposed to be a central feature of the pathophysiology of preeclampsia. However, the mechanism by which this endothelial dysfunction occurs remains uncertain. We investigated the predictive and diagnostic value of serum soluble vascular endothelial growth factor receptor-1 (VEGFR-1) with by comparison of its prepartum and postpartum serum levels in the management of women with PE. Materials and Methods: This prospective case-controlled study was composed of pre-eclamptic (n=44) and normal, healthy pregnant (n=44) women. Blood samples were collected before any intervention at the first antenatal examination of the women in the control group and at the admission of the women to the hospital in the PE group, additionally, from all women in the study groups within six hours of the postpartum period, and used for the serum VEGFR-1 analyses. Results: Within both groups, prepartum serum levels of sVEGFR-1 were higher than postpartum levels (p<0.05). In PE, pre-partum and postpartum serum levels of sVEGFR-1 were higher than levels in the control group (p<0.05). Serum sVEGFR-1 levels of preeclamptic women were positively correlated with the degree of proteinuria (p<0.05, r=0.25), systolic (p<0.05, r=0.25), and diastolic blood pressure (p<0.05, r=0.31). Conclusion: These findings seem to point to an involvement of sVEGFR-1 in the pathophysiology of PE. Serum sVEGFR-1 has the potential to be used as a valuable biomarker in the prediction, diagnosis, and risk management of women with subtypes of PE including mild and severe PE, HELLP syndrome, and eclampsia. There is a need to study serum sVEGFR-1 as a biomarker in pregnant women with different subtypes of PE.

Topics

  • Pregnancy and preeclampsia studies
  • Angiogenesis and VEGF in Cancer
  • Maternal and fetal healthcare

Primary topic Pregnancy and preeclampsia studies

Authors

  1. SULTAN ŞALK
  2. NAZAN YURTCU SİVAS CUMHURİYET ÜNİVERSİTESİ
  3. ALİ ÇETİN